Authors (year)
Subjects (mean age)
Exercise modality
Reps × sets (or time) intensity
Duration frequency
Results
Narici et al. (1989)
4 M (28)
KE (ISOK)
10 × 6
60 days
[CSA]
maximal
4 days/week
20, 30, 40, 50, 60, 70 %SL: ↑, 80 %SL: n.s.
Schott et al. (1995)
1 M, 6 W (23)
KE (ISOM)
a. 3 s × 10 × 4 70 %MVC
14 weeks
[CSA]
b. 30 s × 4 × 1 70 %MVC
3 days/week
a. 25, 75 %SL: n.s.
b. 25, 75 %SL: ↑
Smith and Rutherford (1995)
5 M (21)
a. KE (CON)
10 × 4
20 weeks
[CSA]
5 W (20)
b. KE (ECC)
10RM
3 days/week
a. 25 %SL: ↑, 75 %SL: n.s.
b. 25 %SL: ↑, 75 %SL: n.s.
Higbie et al. (1996)
a. 16 W (20)
a. KE (CON, ISOK)
10 × 3
10 weeks
[CSA]
b. 19 W (20)
b. KE (ECC, ISOK)
maximal
3 days/week
a. 20, 30, 40, 50, 60, 70, 80 %SL: ↑
b. 20, 30, 40, 50, 60, 70, 80 %SL: ↑
Hisaeda et al. (1996)
a. 5 W (20)
KE (CON/ECC)
a. 15 × 5–6 15–20RM
8 weeks
[CSA]
b. 6 W(20)
b. 5 × 8–9 4–5RM
3 days/week
a. 30 %SL: ↑, 50, 70 %SL: n.s.
b. 70 %SL: ↑, 30, 50 %SL: n.s.
Narici et al. (1996)
7 M (29)
KE (CON/ECC)
8 × 6
6 months
[CSA]
80 %1RM
3.5 days/week
30, 40, 50, 60, 70 %SL: ↑
[Relative increase in CSA]
30 %SL > 60 %SL
70 %SL > 40 %SL > 50, 60 %SL
Seger et al. (1998)
a. 5 M (24)
a. KE (CON, ISOK)
10 × 4
10 weeks
[CSA]
b. 5 M (25)
b. KE (ECC, ISOK)
maximal
3 days/week
a. 50 %SL, Distala: n.s.
b. Distal: ↑, 50 %SL: n.s.
Häkkinen et al. (2001)
10 W (64)
KE (CON/ECC)
5–20 × 3–6
21 weeks
[CSA]
LP (CON/ECC)
40–80 %1RM
2 days/week
20, 27, 33, 40, 47, 53, 60, 67, 73 %SL: ↑, 80 %SL: n.s.
Häkkinen et al. (2002)
a. 11 W with FM (39)
KE (CON/ECC)
5–20 × 3–6
21 weeks
[CSA]
b. 10 healthy W (37)
LP (CON/ECC)
40–80 %1RM
2 days/week
a. 20, 27, 33, 40, 47, 53, 60, 67 %SL: ↑, 73, 80 %SL: n.s.
b. 20, 27, 33, 40, 47, 53, 60, 67, 73, 80 %SL: ↑
Häkkinen et al. (2003)
a. 16 M (38)
a. KE (CON/ECC) LP (CON/ECC)
a. 3–15 × 3–6 50–80 %1RM
21 weeks
[CSA]
b. 11 M (37)
b. KE (CON/ECC)
LP (CON/ECC)
Walking
Cycling
b. [RT] 3–15 × 3–6 50–80 %1RM [ET] 30–90 min
a. 2 days/week
a. 20, 27, 33, 40, 47, 53, 60, 67 %SL: ↑, 73 %SL: n.s.
b. 4 days/week (2 for RT and 2 for ET)
b. 20, 27, 33, 40, 47, 53, 60, 67, 73 %SL: ↑
Ahtiainen et al. (2003)
8 M (34)
KE (CON/ECC)
3–15 × 3–6
21 weeks
[CSA]
LP (CON/ECC)
50–80 %1RM
2 days/week
40, 47, 53, 60, 67 %SL: ↑, 20, 27, 33 %SL: n.s.
Blazevich et al. (2007)
12 M (24),
a. KE (CON, ISOK)
6 × 4–6
10 weeks
[Relative increase in CSA]
12 W (21)
b. KE (ECC, ISOK)
maximal
3 days/week
25 %SL vs. 75 %SL: n.s.
Seynnes et al. (2007)
5 M, 2 W (20)
KE (CON/ECC)
7 × 4
5 weeks
[CSA]
maximal
3 days/week
50, 75 %SL: ↑
Melnyk et al. (2009)
a. 11 M (25)
[CSA]
a. 30, 50, 70 %SL: ↑
b. 10 W (26)
KE (CON/ECC)
5–20 × 5
9 weeks
b. 50, 70 %SL: ↑, 30 %SL: n.s.
c. 11 M (69)
50 %1RM–5RM
3 days/week
c. 30, 50, 70 %SL: ↑
d. 11 W (68)
d. 30, 50, 70 %SL: ↑
Hudelmaier et al. (2010)
a. 16 W
a. KE(CON/ECC), LP(CON/ECC), SQ(CON/ECC)
a. 6–12 × 1–3 60–80 %1RM
12 weeks
[CSA]
b. 19 W (51)
b. Cycling
b. 40 min 55–85 %HRmax
3 days/week
a. 10, 20, 30, 40, 50, 60 %SL: ↑, 70, 80, 90 %SL: n.s.
b. 10, 20, 30, 40, 50, 60, 70, 80 %SL: ↑, 90 %SL: n.s.
Petersen et al. (2011)
a. 5 M, 7 W (62)
[CSA]
b. 4 M, 7 W (62)
KE(CON/ECC), LP(CON/ECC)
8–15 × 4–5
12 weeks
a. Middle: ↑, Distal: n.s.
c. 5 M, 7 W (63)b
8–15RM
3 days/week
b. Middle: ↑, Distal: n.s.
c. Middle: ↑, Distal: n.s.c
In addition to the studies listed in Table 14.1, Kanehisa et al. (2003) investigated the changes in QF CSA in junior weight lifters (seven boys). Eighteen months after the baseline measurement, QF CSA increased significantly at 70 % SL, but not at 30 % or 50 %SL. Similarly, Kanehisa et al. (2006) examined changes in QF CSA at 30 %, 50 %, and 70 %SL in teenage tennis players (six boys and six girls) over a 2-year period. In boys, QF CSA increased significantly in all three regions, whereas in girls, QF CSA increased significantly only at 30 % and 50 %SL. Unfortunately, these studies (Kanehisa et al. 2003, 2006) did not include untrained control groups. Therefore, it is unclear whether the nonuniform changes in QF CSA were due to competitive training, natural growth, or both.
14.2.2 Hypertrophic Changes Along the Length of Each Component of the QF
Table 14.2 shows reported regional hypertrophic changes in each component of QF along the length of the muscle. The pattern of hypertrophy along the length varies greatly in each of the vasti [vastus intermedius (VI), vastus lateralis (VL), and vastus medialis (VM)]. As with QF CSA, this variation may be partly attributed to disparities in combinations of training intensity and volume, and in subject characteristics. However, even with similar program variables of training in similar subjects, Narici et al. (1989) and Housh et al. (1992) observed different hypertrophic patterns along the length of the vasti. Regarding this discrepancy, Housh et al. (1992) suggested that there might have been a difference in training status between the dominant (Narici et al. 1989) and non-dominant (Housh et al. 1992) thighs at the beginning of the study. As for the rectus femoris (RF), Ema et al. (2013) reported that the relative increase in CSA was significantly greater at 50 %SL than at 30 %SL. This is consistent with other studies (Housh et al. 1992; Narici et al. 1996; Blazevich et al. 2007), which showed a tendency toward a greater relative increase in RF CSA in the distal region, although statistical analysis between regions was not reported.
Table 14.2
Studies on the training-induced regional changes in CSA of each component of the QF
Authors (year) | Subjects (mean age) | Exercise modality | Reps × sets intensity | Duration frequency | Results |
---|---|---|---|---|---|
Narici et al. (1989) | 4 M (28) | KE (ISOK) | 10 × 6 | 60 days | [VI: CSA] |
maximal | 4 days/week | 30, 40, 60, 70 %SL: ↑, 20, 50, 80 %SL: n.s. | |||
[VL: CSA] | |||||
40 %SL: ↑, 20, 30, 50, 60, 70, 80 %SL: n.s. | |||||
[VM: CSA] | |||||
20, 30, 50, 60, 80 %SL: ↑, 40, 70 %SL: n.s. | |||||
[RF: CSA] | |||||
20, 40, 50 %SL: ↑, 30, 60, 70 %SL: n.s. | |||||
Housh et al. (1992) | 13 M (25) | KE (CON, ISOK) | 10 × 6 | 8 weeks | [VI, VL: CSA] |
maximal | 3 days/week | 50 %SL: ↑, 33, 67 %SL: n.s. | |||
[VM: CSA] | |||||
33, 50, 67 %SL: n.s. | |||||
[RF: CSA] | |||||
33, 50, 67 %SL: ↑ | |||||
Narici et al. (1996) | 7 M (29) | KE (CON/ECC) | 8 × 6 | 6 months | [VI, VL, VM, RF: CSA] |
80 %1RM | 3.5 days/week | 30, 40, 50, 60, 70 %SL: ↑a | |||
Housh et al. (1998) | 9 M (24) | KE (CON) | 6 × 3–5 | 8 weeks | [VI, VL, VM, RF: CSA] |
80 %1RM | 3 days/week | 33, 50, 67 %SL: ↑b | |||
Häkkinen et al. (2001) | 10 W (64) | KE (CON/ECC) | 5–20 × 3–6 | 21 weeks | [VI: CSA] |
LP (CON/ECC) | 40–80 %1RM | 2 days/week | 20, 27, 40, 47, 53, 60, 67 %SL: ↑ | ||
33, 73, 80 %SL: n.s. | |||||
[VL: CSA] | |||||
20, 27, 33, 40, 47, 53 %SL: ↑ | |||||
60, 67, 73 %SL: n.s. | |||||
[VM: CSA] | |||||
47, 53, 60, 67, 73, 80 %SL: ↑ | |||||
20, 27, 33, 40 %SL: n.s. | |||||
[RF: CSA] | |||||
40 %SL: ↑ | |||||
20, 27, 33, 47, 53, 60, 67 %SL: n.s. | |||||
Reeves et al. (2004) | 4 M, 5 W (74) | KE (CON/ECC) | ~10 × 2 | 14 weeks | [VL: CSA] |
LP (CON/ECC) | ~60–80 %5RM | 3 days/week | 12, 15, 18, 21, 24, 27 cm from PI: ↑ | ||
3, 6, 9, 30 cm from PI: n.s. | |||||
Blazevich et al. (2007) | 12 M (24), | a. KE (CON, ISOK) | 6 × 4–6
![]() Stay updated, free articles. Join our Telegram channel![]() Full access? Get Clinical Tree![]() ![]() ![]() |